Published by ChinaMNC · Renhua

World Life Science Conference Debuts in Guangdong: What It Means for Foreign Founders in Biotech

The 2026 World Life Science Conference will be held in Guangzhou from November 28 to 30, marking its first time in Guangdong. For foreign founders in biotech, this signals growing opportunities in the Greater Bay Area. Here's how to set up your China company to take part.

Key Takeaways for International Biotech Founders

The 2026 World Life Science Conference (WLS) will take place in Guangzhou from November 28 to 30 at the Baiyun International Convention Center. This is the first time the event, described as China’s highest-level, most comprehensive, and most influential international academic gathering in life sciences, will be held in Guangdong. For foreign founders in biotech and life sciences, the conference underscores the Greater Bay Area’s push to become a global hub—and highlights why setting up a China entity now can position you to benefit from the region’s growing ecosystem.

While the conference itself is an academic event, it brings together researchers, international organizations, and industry players. For entrepreneurs, the key is to understand how to establish and operate a company in China to engage with this market. Below, we break down the practical steps for foreign founders considering China company registration, using the conference as a backdrop for opportunity.

Why Guangdong and the Greater Bay Area?

Guangdong is already a major economic zone, and the Greater Bay Area (GBA) initiative aims to integrate Hong Kong, Macao, and nine Guangdong cities into a global innovation powerhouse. The life sciences and biopharma sectors are prioritized. The conference’s focus on deepening industry-academia-research collaboration with local Guangdong enterprises, as mentioned in the source, indicates a welcoming environment for foreign expertise and investment. For founders, this means potential partnerships, access to talent, and government support for biotech ventures.

However, to tap into these opportunities, you need a legal presence. Whether you plan to collaborate with local firms, hire researchers, or establish a lab, a China-registered company is often necessary. The good news: the process is streamlined, and foreign ownership is permitted in many sectors, though life sciences may have specific requirements.

Choosing the Right Entity for Your Biotech Startup

Foreign founders typically choose between a Wholly Foreign-Owned Enterprise (WFOE) and a Joint Venture (JV). For life sciences, a WFOE is common if you want full control, but check the Negative List—some activities, like certain medical device manufacturing or genetic research, may require a JV or local partner. A Representative Office (RO) is not suitable for revenue-generating activities.

What this means for your registration: Determine your business scope early. If you plan to conduct R&D, you may need a WFOE with a research-focused scope. If you aim to manufacture or sell products, additional licenses may apply.

Step-by-Step Company Registration

Registering a company in China has become more efficient, but requires careful preparation. Here’s a general roadmap:

• Name pre-approval: Submit proposed names to the local Administration for Market Regulation (AMR). Names must be unique and follow Chinese naming conventions.
• Registered address: You need a physical address in China. Many founders use virtual office or incubator addresses, but for biotech, a lab or office in a designated park may be required.
• Articles of Association: Draft and submit the company charter, specifying business scope, capital, and governance.
• Business license: Once approved, you receive the unified business license, which includes the company’s registration number.
• Post-registration filings: This includes tax registration, bank account opening, and foreign exchange registration.

What this means for your registration: The entire process can take 2–4 weeks if documents are in order. For biotech, additional approvals (e.g., for lab safety or environmental impact) may be needed, so factor in extra time.

Documents You’ll Need

Foreign investors must prepare and notarize several documents. Requirements can vary by city, but typically include:

• Passport copies of legal representatives and shareholders.
• Notarized and apostilled (or consular legalized) certificate of incorporation for the foreign parent company.
• Bank reference letter.
• Proof of registered address (lease agreement).
• Investor’s credit report (sometimes).

What this means for your registration: Start document preparation early. Notarization and legalization can take weeks, especially if your home country is not a party to the Apostille Convention. Work with a professional to avoid delays.

Capital Requirements and Tax Basics

China has largely moved to a subscribed capital system, meaning you can set the registered capital at a reasonable amount and pay it within the business term. However, for certain industries (e.g., those requiring licenses), minimum capital may apply. For a WFOE in biotech R&D, registered capital is often around RMB 1 million, but this is not a legal minimum—it should reflect the scale of operations.

Tax-wise, China’s corporate income tax rate is 25%, but qualified high-tech enterprises (HNTEs) can enjoy a reduced rate of 15%. Biotech companies involved in R&D may also qualify for super-deductions on R&D expenses. VAT rates vary by service (6% for most services, 13% for goods).

What this means for your registration: Plan your capital and tax strategy upfront. Consider applying for HNTE status after registration if you meet the criteria, as it can significantly lower your tax burden.

Licenses and Compliance for Life Sciences

Life sciences is a regulated sector. Depending on your activities, you may need:

• Medical Device Registration: If you manufacture or import medical devices, registration with the NMPA is required.
• Drug Manufacturing License: For pharmaceutical production.
• Laboratory Animal Use License: If conducting animal testing.
• Human Genetic Resources Approval: For research involving human samples.

Additionally, foreign investment in certain areas (e.g., stem cell research) may be restricted. Always check the latest Negative List.

What this means for your registration: Engage a local consultant to map out required licenses before you register. Some licenses require the company to be established first, so sequence your applications carefully.

Leveraging the Conference for Networking and Partnerships

The WLS conference will feature sessions on industry-academia-research collaboration, with participation from international organizations like the Galen Foundation (known as the “Nobel Prize of biopharma”). The event is expected to attract over 120 foreign experts, including more than 20 foreign academicians. For founders, this is a chance to connect with potential partners, investors, and talent.

But to make the most of it, having a China entity allows you to sign agreements, hire staff, and access local incentives. Many GBA cities offer subsidies for biotech startups, but usually require a local legal entity.

What this means for your registration: If you’re serious about the China market, registering before the conference can help you engage more effectively. Consider scheduling meetings with local officials or park representatives during the event.

Next Steps for Foreign Founders

Setting up a company in China is a strategic move for biotech founders looking to tap into the GBA’s growing life sciences ecosystem. While the conference highlights the region’s ambitions, your success depends on getting the legal and operational foundations right. From choosing the right entity to securing licenses, each step requires careful planning.

This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.

Ready to establish your China presence? Foreign founders can contact ChinaMNC on WhatsApp / WeChat at +86 153 1898 8535 for help registering and operating a company in China.